Thursday, September 26, 2019 NIH Awards Contracts to Advance Tuberculosis Immunology Research NIAID has awarded $30 million in first-year funding to establish new centers for tuberculosis immunology research to accelerate progress in TB vaccine development. The contract awards establish three Immune Mechanisms of Protection Against Mycobacterium tuberculosis (IMPAc-TB) Centers to elucidate the immune responses needed to protect against TB-causing bacteria. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID). This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107